Exclusive: PBM unicorn startup Rightway raises $109M, according to filing

04 Apr 2024
(This story is from our new Health Tech newsletter. If you’d like to sign up, just click here .) An upstart pharmacy benefit manager that signed on conglomerate Tyson Foods as a client earlier this year just raised a fresh round of funding, according to a securities filing. Rightway has raised $109 million in new funds, according to a March 29 SEC filing . The filing indicates that March 25 is the date of the first sale of equity securities related to the round. Board members listed in the filing include executives at Thrive Capital and Khosla Ventures, firms that invested in Rightway’s previous round. Jonathan Locker, a board member of Rightway, was also listed on the filing.
The content of the article does not represent any opinions of Synapse and its affiliated companies. If there is any copyright infringement or error, please contact us, and we will deal with it within 24 hours.
Organizations
Indications
-
Targets
-
Drugs
-
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Leverages most recent intelligence information, enabling fullest potential.